Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?

Tsilogianni Z, Baker JR, Papaporfyriou A, Papaioannou AI, Papathanasiou E, Koulouris NG, Daly L, Ito K, Hillas G, Papiris S, Bakakos P, Loukides S.

J Clin Med. 2020 Feb 9;9(2). pii: E473. doi: 10.3390/jcm9020473.

2.

Daily sedation interruption and mechanical ventilation weaning: a literature review.

Vagionas D, Vasileiadis I, Rovina N, Alevrakis E, Koutsoukou A, Koulouris N.

Anaesthesiol Intensive Ther. 2019;51(5):380-389. doi: 10.5114/ait.2019.90921.

3.

Lung Microbiome in Asthma: Current Perspectives.

Loverdos K, Bellos G, Kokolatou L, Vasileiadis I, Giamarellos E, Pecchiari M, Koulouris N, Koutsoukou A, Rovina N.

J Clin Med. 2019 Nov 14;8(11). pii: E1967. doi: 10.3390/jcm8111967. Review.

4.

Buffering Capacity in Sepsis: A Prospective Cohort Study in Critically Ill Patients.

Vasileiadis I, Kompoti M, Rovina N, Tripodaki ES, Filis C, Alevrakis E, Kyriakoudi A, Kyriakopoulou M, Koulouris N, Koutsoukou A.

J Clin Med. 2019 Oct 23;8(11). pii: E1759. doi: 10.3390/jcm8111759.

5.

The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.

Dima E, Kyriakoudi A, Kaponi M, Vasileiadis I, Stamou P, Koutsoukou A, Koulouris NG, Rovina N.

Respir Med. 2019 Oct;157:1-6. doi: 10.1016/j.rmed.2019.08.012. Epub 2019 Aug 21. Review.

PMID:
31450162
6.

Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management.

Kostakou E, Kaniaris E, Filiou E, Vasileiadis I, Katsaounou P, Tzortzaki E, Koulouris N, Koutsoukou A, Rovina N.

J Clin Med. 2019 Aug 22;8(9). pii: E1283. doi: 10.3390/jcm8091283. Review.

7.

Diagnostic accuracy of T2 biomarkers for the prediction of airway eosinophilia in treated smoking asthmatic patients with loss of asthma control.

Papathanasiou E, Bakakos P, Hillas G, Ntontsi P, Blizou M, Kostikas K, Koulouris N, Papiris S, Loukides S.

J Allergy Clin Immunol Pract. 2020 Jan;8(1):385-387.e2. doi: 10.1016/j.jaip.2019.05.052. Epub 2019 Jun 13. No abstract available.

PMID:
31257188
8.

Asthma-chronic obstructive pulmonary disease overlap: Diagnostic stability and inflammatory characteristics.

Patentalakis G, Bakakos P, Papaporfyriou A, Papatheodorou G, Hillas G, Kostikas K, Papiris S, Koulouris N, Loukides S.

Allergy. 2019 Nov;74(11):2271-2273. doi: 10.1111/all.13865. Epub 2019 May 28. No abstract available.

PMID:
31077386
9.

Inflammatory profile in optimally treated patients with adult versus early-onset asthma.

Papaporfyriou A, Papaioannou AI, Hillas G, Konstantelou E, Tseliou E, Koulouris N, Papiris S, Bakakos P, Kostikas K, Loukides S.

Postgrad Med. 2019 Jun;131(5):324-329. doi: 10.1080/00325481.2019.1600884. Epub 2019 Apr 4.

PMID:
30920326
10.

Current clinical management of smoke inhalation injuries: a reality check.

Spinou A, Koulouris NG.

Eur Respir J. 2018 Dec 6;52(6). pii: 1802163. doi: 10.1183/13993003.02163-2018. Print 2018 Dec. No abstract available.

PMID:
30523210
11.

Variation of endothelium-related hemostatic factors during sepsis.

Vasileiadis I, Politou M, Dimopoulos S, Rovina N, Kyriakopoulou M, Kyriakoudi A, Tripodaki ES, Koutsouri T, Terpos E, Koulouris N, Koutsoukou A.

Microcirculation. 2018 Nov;25(8):e12500. doi: 10.1111/micc.12500. Epub 2018 Oct 10.

PMID:
30159948
12.

Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People.

Tatsis N, Kakavas S, Metaxas E, Balis E, Tatsis G, Pantazis N, Bakakos P, Koulouris N, Hadjistavrou Κ.

Open Respir Med J. 2018 Jul 31;12:29-38. doi: 10.2174/1874306401812010029. eCollection 2018.

13.

Acute effects of smoke exposure on airway and systemic inflammation in forest firefighters.

Gianniou N, Giannakopoulou C, Dima E, Kardara M, Katsaounou P, Tsakatikas A, Roussos C, Koulouris N, Rovina N.

J Asthma Allergy. 2018 Apr 23;11:81-88. doi: 10.2147/JAA.S136417. eCollection 2018.

14.

Serum osteopontin in patients with lung cancer and chronic obstructive pulmonary disease: does the co-existence make the difference?

Petta V, Loukides S, Kostikas K, Papaioannou AI, Papatheodorou G, Cholidou K, Tomos I, Papiris S, Koulouris NG, Bakakos P.

J Thorac Dis. 2018 Feb;10(2):740-748. doi: 10.21037/jtd.2018.01.45.

15.

Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease.

Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P, Koulouris N, Tousoulis D.

Echocardiography. 2018 Jun;35(6):804-808. doi: 10.1111/echo.13846. Epub 2018 Feb 28.

PMID:
29490113
16.

Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.

Papaioannou AI, Konstantelou E, Papaporfyriou A, Bartziokas K, Spathis A, Bakakos P, Loukides S, Koulouris N, Papiris S, Kostikas K.

Lung. 2018 Apr;196(2):201-205. doi: 10.1007/s00408-018-0099-5. Epub 2018 Feb 14.

PMID:
29445934
17.

Corrigendum: Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2018 Jan 24;4:257. doi: 10.3389/fmed.2017.00257. eCollection 2017.

18.

Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.

Tzouvelekis A, Karampitsakos T, Kontou M, Granitsas A, Malliou I, Anagnostopoulos A, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Chrysikos S, Dimakou K, Koulouris N, Bouros D.

Pulm Pharmacol Ther. 2018 Apr;49:61-66. doi: 10.1016/j.pupt.2018.01.006. Epub 2018 Jan 31.

PMID:
29366978
19.

Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2017 Nov 29;4:213. doi: 10.3389/fmed.2017.00213. eCollection 2017. Erratum in: Front Med (Lausanne). 2018 Jan 24;4:257.

20.

Exhaled breath temperature in optimally treated asthmatics: severity and underlying mechanisms.

Ntontsi P, Bakakos P, Papathanasiou E, Tsilogianni Z, Kostikas K, Hillas G, Papatheodorou G, Koulouris N, Papiris S, Loukides S.

J Breath Res. 2018 Feb 20;12(2):026013. doi: 10.1088/1752-7163/aa9d46.

PMID:
29176061
21.

Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.

Papaioannou AI, Kostikas K, Papaporfyriou A, Angelakis L, Papathanasiou E, Hillas G, Mazioti A, Bakakos P, Koulouris N, Papiris S, Loukides S.

COPD. 2017 Dec;14(6):635-640. doi: 10.1080/15412555.2017.1386644. Epub 2017 Nov 3.

PMID:
29099646
22.

Does size matter concerning impact of position on oxygenation status in spontaneously breathing patients with unilateral effusion?

Michaelides SA, Michailidis AR, Bablekos GD, Analitis A, Michalatou M, Koulouris N.

Postgrad Med J. 2018 Feb;94(1108):81-86. doi: 10.1136/postgradmedj-2017-135164. Epub 2017 Sep 28.

PMID:
28972098
23.

Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma.

Lappas AS, Tzortzi AS, Konstantinidi EM, Teloniatis SI, Tzavara CK, Gennimata SA, Koulouris NG, Behrakis PK.

Respirology. 2018 Mar;23(3):291-297. doi: 10.1111/resp.13180. Epub 2017 Sep 24.

24.

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.

Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Review. Erratum in: Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:247.

25.

The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.

Tsikrika S, Dimakou K, Papaioannou AI, Hillas G, Thanos L, Kostikas K, Loukides S, Papiris S, Koulouris N, Bakakos P.

Cytokine. 2017 Nov;99:281-286. doi: 10.1016/j.cyto.2017.08.005. Epub 2017 Aug 31.

PMID:
28863927
26.

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.

Tzouvelekis A, Ntolios P, Karampitsakos T, Tzilas V, Anevlavis S, Bouros E, Steiropoulos P, Koulouris N, Stratakos G, Froudarakis M, Bouros D.

Pulm Pharmacol Ther. 2017 Oct;46:48-53. doi: 10.1016/j.pupt.2017.08.011. Epub 2017 Aug 24.

PMID:
28843616
27.

Gaining access to the periphery of the lung: Bronchoscopic and transthoracic approaches.

Touman AA, Vitsas VV, Koulouris NG, Stratakos GK.

Ann Thorac Med. 2017 Jul-Sep;12(3):162-170. doi: 10.4103/atm.ATM_416_16. Review.

28.

Post-pneumonectomy and post-lobectomy syndromes: case series and review of the literature.

Stratakos G, Vitsas V, Koufos N, Zissis C, Emmanouil P, Koulouris N.

Monaldi Arch Chest Dis. 2017 May 18;87(1):810. doi: 10.4081/monaldi.2017.810. Review.

29.

Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits.

Vasilopoulou M, Papaioannou AI, Kaltsakas G, Louvaris Z, Chynkiamis N, Spetsioti S, Kortianou E, Genimata SA, Palamidas A, Kostikas K, Koulouris NG, Vogiatzis I.

Eur Respir J. 2017 May 25;49(5). pii: 1602129. doi: 10.1183/13993003.02129-2016. Print 2017 May.

30.

Serum periostin in patients hospitalized for COPD exacerbations.

Konstantelou E, Papaioannou AI, Loukides S, Bartziokas K, Papaporfyriou A, Papatheodorou G, Bakakos P, Papiris S, Koulouris N, Kostikas K.

Cytokine. 2017 May;93:51-56. doi: 10.1016/j.cyto.2017.05.007. Epub 2017 May 13.

PMID:
28511944
31.

Initial size of unilateral pleural effusion determines impact of thoracocentesis on oxygenation.

Michaelides SA, Bablekos GD, Analitis A, Michailidis AR, Charalabopoulos KA, Koulouris N.

Postgrad Med J. 2017 Nov;93(1105):691-695. doi: 10.1136/postgradmedj-2017-134854. Epub 2017 Apr 25.

PMID:
28442619
32.

Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes.

Ntontsi P, Loukides S, Bakakos P, Kostikas K, Papatheodorou G, Papathanassiou E, Hillas G, Koulouris N, Papiris S, Papaioannou AI.

Allergy. 2017 Nov;72(11):1761-1767. doi: 10.1111/all.13184. Epub 2017 May 11.

PMID:
28407269
33.

The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics.

Konstantellou E, Loukides S, Ntontsi P, Papathanasiou E, Kostikas K, Paptheodorou G, Hillas G, Papiris S, Koulouris NG, Bakakos P.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1129-1131.e3. doi: 10.1016/j.jaip.2017.03.005. Epub 2017 Apr 7. No abstract available.

PMID:
28396112
34.

Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.

Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E.

JACC Cardiovasc Imaging. 2017 Dec;10(12):1437-1447. doi: 10.1016/j.jcmg.2016.11.019. Epub 2017 Mar 15.

35.

Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients.

Theodorakopoulou EP, Gennimata SA, Harikiopoulou M, Kaltsakas G, Palamidas A, Koutsoukou A, Roussos C, Kosmas EN, Bakakos P, Koulouris NG.

Respir Physiol Neurobiol. 2017 Apr;238:47-54. doi: 10.1016/j.resp.2017.01.008. Epub 2017 Jan 18.

PMID:
28109942
36.

Activin A and follistatin in patients with asthma. Does severity make the difference?

Papaporfyriou A, Bakakos P, Kostikas K, Papatheodorou G, Hillas G, Trigidou R, Katafigiotis P, Koulouris NG, Papiris SA, Loukides S.

Respirology. 2017 Apr;22(3):473-479. doi: 10.1111/resp.12937. Epub 2016 Nov 2.

PMID:
27807906
37.

Sputum interleukin-13 as a biomarker for the evaluation of asthma control.

Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K.

Clin Exp Allergy. 2016 Nov;46(11):1498. doi: 10.1111/cea.12825. No abstract available.

PMID:
27790845
38.

Prolonged occupational exposure leads to allergic airway sensitization and chronic airway and systemic inflammation in professional firefighters.

Gianniou N, Katsaounou P, Dima E, Giannakopoulou CE, Kardara M, Saltagianni V, Trigidou R, Kokkini A, Bakakos P, Markozannes E, Litsiou E, Tsakatikas A, Papadopoulos C, Roussos C, Koulouris N, Rovina N.

Respir Med. 2016 Sep;118:7-14. doi: 10.1016/j.rmed.2016.07.006. Epub 2016 Jul 13.

39.

Predictors of future exacerbation risk in patients with asthma.

Papaioannou AI, Kostikas K, Bakakos P, Papaporfyriou A, Konstantellou E, Hillas G, Papatheodorou G, Koulouris NG, Papiris S, Loukides S.

Postgrad Med. 2016 Sep;128(7):687-92. doi: 10.1080/00325481.2016.1220807. Epub 2016 Aug 17.

PMID:
27494758
40.

Interval training induces clinically meaningful effects in daily activity levels in COPD.

Louvaris Z, Spetsioti S, Kortianou EA, Vasilopoulou M, Nasis I, Kaltsakas G, Koulouris NG, Vogiatzis I.

Eur Respir J. 2016 Aug;48(2):567-70. doi: 10.1183/13993003.00679-2016. Epub 2016 Jun 23. No abstract available.

41.

Survival and Quality of Life Benefit after Endoscopic Management of Malignant Central Airway Obstruction.

Stratakos G, Gerovasili V, Dimitropoulos C, Giozos I, Filippidis FT, Gennimata S, Zarogoulidis P, Zissimopoulos A, Pataka A, Koufos N, Zakynthinos S, Syrigos K, Koulouris N.

J Cancer. 2016 Apr 25;7(7):794-802. doi: 10.7150/jca.15097. eCollection 2016.

42.

Sputum interleukin-13 as a biomarker for the evaluation of asthma control.

Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K.

Clin Exp Allergy. 2016 Jul;46(7):923-31. doi: 10.1111/cea.12729. Epub 2016 May 3. Erratum in: Clin Exp Allergy. 2016 Nov;46(11):1498.

PMID:
26990030
43.

Fever and multilobular mass of the right lung in a young adult with asthma.

Sotiriou A, Koulouris N, Bakakos P.

Med Mycol Case Rep. 2015 Dec 5;10:7-10. doi: 10.1016/j.mmcr.2015.12.001. eCollection 2015 Dec.

44.

Respiratory mechanics in brain injury: A review.

Koutsoukou A, Katsiari M, Orfanos SE, Kotanidou A, Daganou M, Kyriakopoulou M, Koulouris NG, Rovina N.

World J Crit Care Med. 2016 Feb 4;5(1):65-73. doi: 10.5492/wjccm.v5.i1.65. eCollection 2016 Feb 4. Review.

45.

Changes in BODE Quartiles After Pulmonary Rehabilitation Do Not Predict 2-Year Survival in Patients With COPD.

Kavoura P, Kostikas K, Tselebis A, Bratis D, Kosmas E, Alchanatis M, Koulouris NG, Bakakos P, Loukides S.

J Cardiopulm Rehabil Prev. 2016 Jan-Feb;36(1):62-7. doi: 10.1097/HCR.0000000000000157.

PMID:
26629865
46.

Therapeutic exercise in improving acute lung injury: a long distance to be covered.

Rovina N, Koutsoukou A, Koulouris N.

Ann Transl Med. 2015 Oct;3(18):273. doi: 10.3978/j.issn.2305-5839.2015.09.13. No abstract available.

47.

Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.

Konstantellou E, Papaioannou AI, Loukides S, Patentalakis G, Papaporfyriou A, Hillas G, Papiris S, Koulouris N, Bakakos P, Kostikas K.

Respir Med. 2015 Nov;109(11):1404-9. doi: 10.1016/j.rmed.2015.09.009. Epub 2015 Sep 21.

48.

Hemodynamic effects of high intensity interval training in COPD patients exhibiting exercise-induced dynamic hyperinflation.

Nasis I, Kortianou E, Vasilopoulou Μ, Spetsioti S, Louvaris Z, Kaltsakas G, Davos CH, Zakynthinos S, Koulouris NG, Vogiatzis I.

Respir Physiol Neurobiol. 2015 Oct;217:8-16. doi: 10.1016/j.resp.2015.06.006. Epub 2015 Jun 23.

PMID:
26112284
49.

Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD).

Dima E, Koltsida O, Katsaounou P, Vakali S, Koutsoukou A, Koulouris NG, Rovina N.

Cytokine. 2015 Aug;74(2):313-7. doi: 10.1016/j.cyto.2015.04.008. Epub 2015 Apr 25. Review.

PMID:
25922275
50.

Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma.

Rovina N, Dima E, Bakakos P, Tseliou E, Kontogianni K, Papiris S, Koutsoukou A, Koulouris NG, Loukides S.

Respir Med. 2015 May;109(5):580-7. doi: 10.1016/j.rmed.2015.03.002. Epub 2015 Mar 19.

Supplemental Content

Loading ...
Support Center